BACTERIOSTATIC WATER FOR INJECTION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• On June 2024, Zydus Life Sciences modified its Biotax 1g injection by including 10ml sterile water in Nepal after the country's drug regulator raised concerns over the initial 5ml supply. This change was made to ensure proper dosing for both intramuscular and intravenous use. Zydus emphasized that the adjustment was for convenience and did not affect the product's quality or safety.
• On June 2024, On June 13, 2024, Asahi Kasei launched a new membrane system designed for producing Water for Injection (WFI), a type of sterile water used in preparing injections. This system uses Microza hollow-fiber membranes as an alternative to traditional distillation processes, significantly reducing CO2 emissions and production costs by minimizing the need for steam generation. The system, known for its high filtration performance, offers advantages such as higher water quality, simplified processes, and an impressive endotoxin removal rate of over 99.999%, compared to 99.9% with distillation.
• In May 2021 Hospira, Inc., a Pfizer company, recalled lot DN9185 of Sterile Water for Injection, USP, 100 mL Single Dose Glass Fliptop Vials due to a confirmed report of visible particulate in a vial. While the risk to patients is low, potential adverse events could include anaphylaxis, fever, vein irritation, and other serious conditions.
• In July 2021, Nexus Pharmaceuticals introduced potassium chloride in water for injection, available in single-dose IV bags with concentrations of 10mEq/100mL, 10mEq/50mL, and 20mEq/50mL. This injectable form of potassium chloride is used to treat potassium deficiency when oral supplementation is not feasible​